3-Year safety check for Kids' arthritis and Behçet's disease medication
NCT ID NCT05767047
Summary
This study follows children who have already been taking apremilast for Behçet's disease mouth ulcers or juvenile psoriatic arthritis to check its long-term safety over three more years. It involves about 48 children aged 2-17 who completed a previous one-year study. Researchers will monitor side effects, growth, and overall health to ensure the medication remains safe for extended use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BEHÇET'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
General Hospital of Thessaloniki Ippokrateio
RECRUITINGThessaloniki, 54642, Greece
-
Hacettepe Universitesi Tip Fakultesi Hastanesi
RECRUITINGAnkara, 06100, Turkey (Türkiye)
-
Hospital Universitari i Politecnic La Fe
RECRUITINGValencia, Valencia, 46026, Spain
-
Hospital Universitario Ramon y Cajal
RECRUITINGMadrid, 28034, Spain
-
Istanbul Universitesi Cerrahpasa Tip Fakultesi
RECRUITINGIstanbul, 34098, Turkey (Türkiye)
-
Meir Medical Center
RECRUITINGKfar Saba, 4428164, Israel
-
Umraniye Egitim ve Arastirma Hastanesi
RECRUITINGIstanbul, 34764, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.